Spacer Fidelity Assessments of Guide RNA by Top-Down Mass Spectrometry

September 13, 2023

Overview

This on-demand presentation explores how top-down mass spectrometry (MS/MS) provides direct and quantitative assessments of highly modified CRISPR guide RNAs (gRNAs), ensuring their accuracy and safety for therapeutic applications.

Discover:

  • The role of gRNA spacer fidelity in CRISPR-based gene editing
  • How MS/MS analyzes gRNA spacer characterization and identifies impurities
  • Automated software tools for accurate gRNA sequencing and quantification
  • De novo sequencing strategies to decipher highly dissimilar spacer impurities

This presentation is for you if:

  • You are involved in the development of CRISPR-based biotherapeutics
  • You need to ensure the quality and safety of gRNA used in your research    
  • You are interested in cutting-edge technologies for gRNA analysis

Don't miss this opportunity to learn how top-down MS/MS can revolutionize your CRISPR research and development.

By the end of this presentation, you will have:

  • A deeper understanding of gRNA spacer characterization by MS/MS
  • The knowledge to analyze gRNA impurities and ensure their negligible levels
  • Access to powerful software tools for automated gRNA analysis

Speaker

Luis A. Macias, Ph.D., Mass Spectrometry Scientist, Verve Therapeutics, Houston, TX, USA

Luis joined Verve in 2022 as a mass spectrometry scientist focusing on support and development of gRNA characterization methods. Prior to joining Verve, Luis was a graduate student in the Brodbelt lab at the University of Texas, where he developed mass spectrometry-based methods to examine structural features of proteins and lipids.

 

For Research Use Only. Not for use in clinical diagnostic procedures.